NeoGenomics's market cap is currently $1.13B. The company's EPS TTM is $0.03; its P/E ratio is ―; NeoGenomics is scheduled to report earnings on July 29, 2025, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
